Intrinsic Value of S&P & Nasdaq Contact Us

ImageneBio Inc IMA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.33
-76.5%

ImageneBio Inc (IMA) has 20 known insider and institutional holders on record. The largest holder is OrbiMed Genesis GP LLC with 1,912,678 shares. Other notable holders include Atlas Venture Fund XI, L.P. and Germa Caroline.

Over the last 12 months, insiders have made 23 transactions in IMA stock — 12 buys (valued at $1.06M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

IMA Insider Ownership

Top Holder
OrbiMed Genesis GP LLC
1,912,678 shares
Buys (12 mo)
12
$1.06M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 52%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Orbimed Genesis Gp Llc Director 1,912,678 2022-06-24
100%
2 Atlas Venture Fund Xi, L.p. 10 Percent Owner 874,634 2021-12-14
46%
3 Germa Caroline Chief Medical Officer 579,100 2024-03-05
30%
4 Manfredi Mark President & CEO 320,000 2024-02-02
17%
5 Orbimed Advisors Llc Director 287,885 2025-07-30
15%
6 Santillana Sergio L. Chief Medical Officer 105,000 2023-01-05
5%
7 Zhang Xiaoyan Michelle Chief Scientific Officer 105,000 2023-01-05
5%
8 Ecsedy Jeffrey Chief Development Officer 100,000 2024-02-02
5%
9 Yarema Kristin Chief Executive Officer 85,400 2026-03-18
4%
10 Tessier Maude Chief Business Officer 40,000 2022-02-04
2%
11 Wang Jonathan Jian Director 31,200 2025-12-22
2%
12 Wang Stephen Hui Director 31,200 2025-12-22
2%
13 Quelch John Director 24,204 2007-11-20
1%
14 Butler Erin Principal Accounting Officer 22,500 2026-01-02
1%
15 Bonita David P Director 17,520 2024-06-10
1%
16 Koehler Maria Director 17,520 2024-06-10
1%
17 Formela Jean Francois Director 17,520 2024-06-10
1%
18 Hughes Owen Director 17,520 2024-06-10
1%
19 Wooster Richard Director 17,520 2024-06-10
1%
20 Dukes Iain D. Director 17,520 2024-06-10
1%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-16 Yarema Kristin Chief Executive Officer RSU Award 85,400 - -
2026-02-16 Porter-brown Benjamin Officer Unknown - - -
2025-12-30 Butler Erin Principal Accounting Officer RSU Award 22,500 $7.11 $159.98K
2025-12-24 Slattery Joseph P Director Informative Buy 16,000 $5.99 $95.84K
2025-12-18 Wang Stephen Hui Director RSU Award 31,200 $6.19 $193.13K
2025-12-18 Wang Jonathan Jian Director RSU Award 31,200 $6.19 $193.13K
2025-12-18 Slattery Joseph P Director RSU Award 31,200 $6.19 $193.13K
2025-11-01 Slattery Joseph P Officer Unknown - - -
2025-07-25 Wang Stephen Hui Director RSU Award 12,535 - -
2025-07-25 Wang Stephen Hui Officer Unknown - - -
2025-07-25 Wang Jonathan Jian Director RSU Award 143,832 - -
2025-07-25 Wang Jonathan Jian Officer Unknown - - -
2025-07-25 Lu Yufang Chief Medical Officer RSU Award 4,591 $4.59 $21.07K
2025-07-25 Lu Yufang Officer Unknown - - -
2025-07-28 Yarema Kristin Chief Executive Officer RSU Award 153,505 - -
2025-07-25 Bonita David P Director Option Exercise (Sell) 17,520 $1.75 $30.66K
2025-07-25 Stampacchia Otello Director Option Exercise (Sell) 17,520 $1.75 $30.66K
2025-07-25 Orbimed Advisors Llc Director RSU Award 83,611 $2.49 $208.19K
2025-07-25 Butler Erin Principal Accounting Officer RSU Award 3,051 - -
2025-07-25 Butler Erin Officer Unknown - - -
2025-07-25 Yarema Kristin Officer Unknown - - -
2025-07-28 Marango Jotin Chief Financial Officer Tax Withholding of RSU 4,630 $17.16 $79.45K
2025-07-25 Marango Jotin Chief Financial Officer Return of Shares 397,199 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message